Latest Carpuject Stories

LAKE FOREST, Ill., April 11, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that the company will present at the Bank of America / Merrill Lynch 2011 Health Care Conference on Wednesday, May 11, 2011, in Las Vegas. The presentation is scheduled to begin at 8:40 a.m. Pacific time on Wednesday, May 11, 2011. It will be available to all interested parties through a live audiocast accessible via the...

LAKE FOREST, Ill., April 4, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that it will host a conference call to discuss its first-quarter 2011 results on Tuesday, April 26, 2011 at 8 a.m. Central time. The company will release its first-quarter results earlier that morning, before the U.S. stock market open and the conference call. A live webcast of the conference call and related material will be...

YORK, Pa., March 29, 2011 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (Nasdaq: UNIS; ASX: UNS) today announced it has commenced initial production of the Unifill® ready-to-fill (prefilled) syringe at its FDA-registered manufacturing facility in York, Pennsylvania. The initial production of the Unifill syringe, the world's first prefilled syringe with safety features fully integrated within the glass barrel, will enable Unilife to further accelerate discussions with...

LAKE FOREST, Ill., March 9, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced U.S. Food and Drug Administration (FDA) approval of docetaxel. The medication is a generic version of Sanofi-Aventis's Taxotere®, and Hospira expects to launch the product later this month. Hospira's docetaxel is approved for the treatment of a variety of cancers. In 2010, U.S. sales of Taxotere were approximately $1.2 billion. Unlike...

LAKE FOREST, Ill., March 3, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today launched a new online U.S. product catalog, available at Hospira.com/catalog. Developed with input from customers, the new website allows healthcare facilities and other medical care providers to search Hospira's more than 1,200 products in a variety of ways - alphabetically, by product name, list number, or therapeutic class. To view the...

ORLANDO, Fla., Feb. 23, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a leading provider of clinical information and medication delivery technologies, today announced the unveiling of the Hospira MedNet(TM) Portal at the Healthcare Information and Management Systems Society (HIMSS) Annual Conference and Exhibition in Orlando. This web-based application will provide healthcare institutions with advanced medication error reporting and patient safety benchmarking capabilities. It will be...

LAKE FOREST, Ill., Feb. 14, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced that the company will present at two upcoming conferences: -- Raymond James 32nd Institutional Investors Conference March 8, 2011 (Tuesday) - Orlando, Fla. 9:15 a.m. Eastern time -- Barclays Capital 2011 Global Healthcare Conference March 16, 2011...

LAKE FOREST, Ill., Feb. 3, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced U.S. Food and Drug Administration (FDA) approval of Topotecan Injection, the first solution formulation of the oncology drug approved in the United States. The medication is a generic version of Hycamtin®, which had 2010 U.S. sales of more than $140 million. Hospira's topotecan is indicated for treatment of small cell lung cancer (SCLC)...

LAKE FOREST, Ill., Jan. 25, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, will host a conference call to discuss its fourth-quarter and full-year 2010 results and projections for 2011 on Wednesday, Feb. 2, 2011, at 8 a.m. Central time. The company will release its fourth-quarter and full-year 2010 results earlier that morning, before the U.S. stock market open and the conference call. A live webcast of the...

LAKE FOREST, Ill., Dec. 13, 2010 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that the company will present at the J.P. Morgan 29th Annual Healthcare Conference on Tuesday, Jan. 11, 2011, in San Francisco. The presentation is scheduled to begin at 10:30 a.m. Pacific time on Tuesday, Jan. 11, 2011. It will be available to all interested parties through a live audiocast accessible via the...